Fig. 2
From: Immunized mice naturally process in silico-derived peptides from the nucleocapsid of SARS-CoV-2
Immunogenicity of Nrec in immunized mice. (a) Indirect ELISA. Nrec (1,000–62.5 ng/µL) was used as antigen. (b) Dot blotting. The antigen was fixed to a final concentration of 1 µg. (c) Western blotting. MWM: Molecular weight marker. Black arrow indicates Nrec. In all experiments, we used serum samples derived from immunized mice as the primary antibody and mice anti-IgG coupled to HRP (1:10,000) as the secondary antibody. The blots were edited using clear delineation with dividing lines. Full-length blots are included in Fig S2 [see Supplementary Information file 1]